QualityStocks'  Instablog

Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Prana Biotechnology (PRAN) Secures European and U.S. Patents for Pharmaceutical Compounds 0 comments
    Aug 25, 2010 2:05 PM | about stocks: PRAN

    Prana Biotechnology was established to commercialize research into Alzheimer’s disease and other major age-related neurodegenerative disorders. In line with this objective, the company yesterday announced it has received key PBT2 patents in Europe and the United States for select pharmaceutical compositions.

    “The grant and extension of PBT2 patent rights in the United States together with securing European patent rights marks a critical milestone in our commercialization plans, offering opportunity in both Huntington’s disease and Alzheimer’s disease,” Geoffrey Kempler, Prana’s executive chairman stated in the press release.

    The U.S. Patent and Trademark Office (USPTO) granted Prana a composition of matter patent titled ‘8-Hydroxyquinoline derivatives’ for selected 8-hydroxyquinoline compounds, including its lead clinical asset, PBT2.

    The USPTO also extended the term of the PBT2 patent for another 2.5 years, with a set expiration date of December 21, 2025, though the date may be further extended by the application of pharmaceutical extension of term provisions in that country.

    Prana previously announced the grant of the related European case, and yesterday announced the expiration of the mandatory nine-month post-grant opposition, which releases the company from any third-party objections regarding the patent. The European case has now been placed on the Register of European patents, with a 20-year expiration set for July 16, 2023, and a possible extension of term of up to five years.

    For more information visit pranabio.com.

    Please see disclaimer on QualityStocks website: disclaimer.qualitystocks.net

    Disclosure: no positions

    Stocks: PRAN
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.